Shin JG - Search Results

1

A haplotype of CYP2C9 associated with warfarin sensitivity in mechanical heart valve replacement patients.

Lee SJ, Jang YJ, Cha EY, Kim HS, Lee SS, Shin JG. Lee SJ, et al. Among authors: shin jg. Br J Clin Pharmacol. 2010 Aug;70(2):213-21. doi: 10.1111/j.1365-2125.2010.03688.x. Br J Clin Pharmacol. 2010. PMID: 20653674 Free PMC article.

2

Relationship of paroxetine disposition to metoprolol metabolic ratio and CYP2D6*10 genotype of Korean subjects.

Yoon YR, Cha IJ, Shon JH, Kim KA, Cha YN, Jang IJ, Park CW, Shin SG, Flockhart DA, Shin JG. Yoon YR, et al. Among authors: shin sg, shin jg. Clin Pharmacol Ther. 2000 May;67(5):567-76. doi: 10.1067/mcp.2000.106128. Clin Pharmacol Ther. 2000. PMID: 10824636

3

Frequency of cytochrome P450 2C9 mutant alleles in a Korean population.

Yoon YR, Shon JH, Kim MK, Lim YC, Lee HR, Park JY, Cha IJ, Shin JG. Yoon YR, et al. Among authors: shin jg. Br J Clin Pharmacol. 2001 Mar;51(3):277-80. doi: 10.1046/j.1365-2125.2001.00340.x. Br J Clin Pharmacol. 2001. PMID: 11298075 Free PMC article.

4

Induction of inducible nitric oxide synthase and proinflammatory cytokines expression by o,p'-DDT in macrophages.

Kim JY, Choi CY, Lee KJ, Shin DW, Jung KS, Chung YC, Lee SS, Shin JG, Jeong HG. Kim JY, et al. Among authors: shin dw, shin jg. Toxicol Lett. 2004 Mar 7;147(3):261-9. doi: 10.1016/j.toxlet.2003.12.001. Toxicol Lett. 2004. PMID: 15104118

5

Potential of pranlukast and zafirlukast in the inhibition of human liver cytochrome P450 enzymes.

Liu KH, Lee YM, Shon JH, Kim MJ, Lee SS, Yoon YR, Cha IJ, Shin JG. Liu KH, et al. Among authors: shin jg. Xenobiotica. 2004 May;34(5):429-38. doi: 10.1080/00498250410001691253. Xenobiotica. 2004. PMID: 15370959

6

Genetic polymorphism of CYP2C9 in a Vietnamese Kinh population.

Lee SS, Kim KM, Thi-Le H, Yea SS, Cha IJ, Shin JG. Lee SS, et al. Among authors: shin jg. Ther Drug Monit. 2005 Apr;27(2):208-10. doi: 10.1097/01.ftd.0000153402.91854.42. Ther Drug Monit. 2005. PMID: 15795654

7

Chlorpropamide 2-hydroxylation is catalysed by CYP2C9 and CYP2C19 in vitro: chlorpropamide disposition is influenced by CYP2C9, but not by CYP2C19 genetic polymorphism.

Shon JH, Yoon YR, Kim MJ, Kim KA, Lim YC, Liu KH, Shin DH, Lee CH, Cha IJ, Shin JG. Shon JH, et al. Among authors: shin dh, shin jg. Br J Clin Pharmacol. 2005 May;59(5):552-63. doi: 10.1111/j.1365-2125.2005.02364.x. Br J Clin Pharmacol. 2005. PMID: 15842554 Free PMC article.

8

Identification and functional characterization of novel CYP2J2 variants: G312R variant causes loss of enzyme catalytic activity.

Lee SS, Jeong HE, Liu KH, Ryu JY, Moon T, Yoon CN, Oh SJ, Yun CH, Shin JG. Lee SS, et al. Among authors: shin jg. Pharmacogenet Genomics. 2005 Feb;15(2):105-13. doi: 10.1097/01213011-200502000-00006. Pharmacogenet Genomics. 2005. PMID: 15861034

9

MDR1 genetic polymorphisms and comparison of MDR1 haplotype profiles in Korean and Vietnamese populations.

Lee SS, Kim SY, Kim WY, Thi-Le H, Yoon YR, Yea SS, Shin JG. Lee SS, et al. Among authors: shin jg. Ther Drug Monit. 2005 Aug;27(4):531-5. doi: 10.1097/01.ftd.0000164293.75854.11. Ther Drug Monit. 2005. PMID: 16044113

10

In vitro metabolism of a new cardioprotective agent, KR-33028 in the human liver microsomes and cryopreserved human hepatocytes.

Kim H, Yoon YJ, Kim H, Cha EY, Lee HS, Kim JH, Yi KY, Lee S, Cheon HG, Yoo SE, Lee SS, Shin JG, Liu KH. Kim H, et al. Among authors: shin jg. Arch Pharm Res. 2005 Nov;28(11):1287-92. doi: 10.1007/BF02978214. Arch Pharm Res. 2005. PMID: 16350857

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

359 results

Search Page

Filters